𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A cost-effectiveness analysis of RA biologics

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
335 KB
Volume
58
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of Guillain-BarrΓ© syndrome: A
Treatment of Guillain-BarrΓ© syndrome: A cost-effectiveness analysis
✍ Seema Nagpal; Tim Benstead; Kenneth Shumak; Gail Rock; Murray Brown; David R. An πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 59 KB

Acute Guillain-Barre Β΄syndrome is the most common cause of neuromuscular paralysis. Plasma exchange and intravenous immune globulin (IV IgG) are both effective treatments for this condition and the purpose of this report was to compare the cost-effectiveness of these two modalities. A MEDLINE search

Cost-effectiveness analysis of the Lyme
Cost-effectiveness analysis of the Lyme disease vaccine
✍ Elizabeth C. Hsia; James B. Chung; J. Sanford Schwartz; Daniel A. Albert πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views
Cost-effectiveness of antidepressant med
Cost-effectiveness of antidepressant medications
✍ Thomas W. Croghan; Catherine A. Melfi; William E. Crown; Anita Chawla πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 2 views

Background: Antidepressant medications have been shown to effectively relieve symptoms, improve interpersonal and occupational functioning and reduce disability from coexisting medical conditions. Although the newer selective serotonin reuptake inhibitors (SSRIs) have improved tolerability, are easi

Development of WHO guidelines on general
Development of WHO guidelines on generalized cost-effectiveness analysis
✍ Murray, Christopher J.L. (author);Evans, David B. (author);Acharya, Arnab (autho πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 140 KB

The growing use of cost-effectiveness analysis (CEA) to evaluate specific interventions is dominated by studies of prospective new interventions compared with current practice. This type of analysis does not explicitly take a sectoral perspective in which the costs and effectiveness of all possible